Marine Algal Compounds with Antimicrobial Activities
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 2534
Special Issue Editor
Interests: natural products chemistry; bioactive metabolites; structural characterization; NMR; mass spectrometry; lipidomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Photosynthetic organisms represent an important source of bioactive compounds that can be exploited in pharmaceutical and nutraceutical sectors. In the marine environment, macroalgae and microalgae are among the main reported sources of marine natural products for discovering novel drugs. Widely distributed, they can survive in extreme conditions and produce highly diverse secondary metabolites, including terpenoids, peptides, and fatty acid derivatives. The focus of this Special Issue is on novel metabolites from algae that show promising bioactivities, particularly against resistant bacteria and viruses. The recent COVID-19 pandemic highlighted the need for antiviral drugs. On the other hand, the difficulties encountered in the treatment of infections caused by microorganisms no longer responding to antimicrobial medicines necessitate the discovery and selection of more effective antibiotics.
Original research studies and literature reviews on algal-derived novel chemical structures with promising activities to fight antimicrobial resistance (AMR) are welcome.
Dr. Adele Cutignano
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine microalgae
- marine macroalgae
- secondary metabolites
- structural characterization
- AMR
- antibiotic
- antiviral
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
